IP Library Granted Patent US 7,112,662
Granted Patent B2
US 7,112,662 · App. 10/490,125 · Granted Sep 26, 2006

Anti-metasin antibodies and their methods of use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,112,662
App. No.
10/490,125
Granted
Sep 26, 2006
Kind
B2
Abstract

The present invention aims at providing an antibody, by which metastin or its derivative can be quantified specifically with a high sensitivity, a method of detecting/quantifying metastin or its derivative using the antibody, and a diagnostic agent (e.g., a diagnostic for pregnancy) the same. Specifically, an antibody capable of specifically reacting with a partial peptide at the N-terminus or C-terminus of a polypeptide having the amino acid sequence represented by SEQ ID NO: 1 or its derivative, and a method of detecting/quantifying metastin or its derivative using the antibody as well as a diagnostic agent using the same.

Claims (8)

1. An isolated monoclonal antibody named KIS-1Ca that is produced by the hybridoma cell line deposited with the International Patent Organisms Depository (IPOD) as accession number FERM BP-7430.

2. An isolated monoclonal antibody wherein the isolated monoclonal antibody:

(i) is capable of specifically reacting with the C-terminal region of SEQ ID NO: 1, wherein the C-terminal region consists of SEQ ID NO: 6,

(ii) has a neutralizing activity to a peptide having the amino acid sequence of SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, or SEQ ID NO: 9, and

(iii) is named Kis-1Ca and is produced by the hybridoma cell line deposited with the International Patent Organisms Depository (IPOD) as accession number FERM BP-7430.

3. The antibody according to claim 1 or claim 2 , which is labeled.

4. The hybridoma cell line deposited with the International Patent Organisms Depository (IPOD) as accession number FERM BP-7430.

5. The hybridoma cell line producing the monoclonal antibody according to claim 1 or claim 2 , which is deposited with the International Patent Organisms Depository (IPOD) as accession number FERM BP-7430.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 14, 2007
From: TAKEDA CHEMICAL INDUSTRIES, LTD.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 019013/0140 →
CHANGE OF NAME Recorded Aug 18, 2006
From: TAKEDA CHEMICAL INDUSTRIES, LTD.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 018203/0938 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2004
From: MATSUMOTO, HIROKAZU; HORIKOSHI, YASUKO; KITADA, CHIEKO; OHTAKI, TETSUYA
To: TAKEDA CHEMICAL INDUSTRIES LTD.
Reel/Frame 015567/0240 →